ESR1 and triple-negative breast carcinoma: These disparities are particularly evident in the context of triple-negative breast cancer (TNBC), a subtype characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).